Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Bilavsky, Efraim
Schwaber, Mitchell J
and
Carmeli, Yehuda
2010.
How to stem the tide of carbapenemase-producing Enterobacteriaceae?: proactive versus reactive strategies.
Current Opinion in Infectious Diseases,
Vol. 23,
Issue. 4,
p.
327.
Netikul, Thidarat
Leelaporn, Amornrut
Leelarasmee, Amorn
and
Kiratisin, Pattarachai
2010.
In vitro activities of fosfomycin and carbapenem combinations against carbapenem non-susceptible Escherichia coli and Klebsiella pneumoniae.
International Journal of Antimicrobial Agents,
Vol. 35,
Issue. 6,
p.
609.
Ben-David, Debby
Masarwa, Samira
Navon-Venezia, Shiri
Mishali, Hagit
Fridental, Ilan
Rubinovitch, Bina
Smollan, Gill
Carmeli, Yehuda
and
Schwaber, Mitchell J.
2011.
Carbapenem-ResistantKlebsiella pneumoniaein Post-Acute-Care Facilities in Israel.
Infection Control & Hospital Epidemiology,
Vol. 32,
Issue. 9,
p.
845.
Borer, Abraham
Eskira, Seada
Nativ, Ronit
Saidel-Odes, Lisa
Riesenberg, Klaris
Livshiz-Riven, Ilana
Schlaeffer, Francisc
Sherf, Michael
and
Peled, Nejama
2011.
A Multifaceted Intervention Strategy for Eradication of a Hospital-Wide Outbreak Caused by Carbapenem-Resistant Klebsiella pneumoniae in Southern Israel.
Infection Control & Hospital Epidemiology,
Vol. 32,
Issue. 12,
p.
1158.
Zuckerman, T
Benyamini, N
Sprecher, H
Fineman, R
Finkelstein, R
Rowe, J M
and
Oren, I
2011.
SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state.
Bone Marrow Transplantation,
Vol. 46,
Issue. 9,
p.
1226.
Schwaber, M. J.
Lev, B.
Israeli, A.
Solter, E.
Smollan, G.
Rubinovitch, B.
Shalit, I.
and
Carmeli, Y.
2011.
Containment of a Country-wide Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in Israeli Hospitals via a Nationally Implemented Intervention.
Clinical Infectious Diseases,
Vol. 52,
Issue. 7,
p.
848.
Ho, Vanessa P.
Jenkins, Stephen G.
Afaneh, Cheguevara I.
Turbendian, Harma K.
Nicolau, David P.
and
Barie, Philip S.
2011.
Use of Meropenem by Continuous Infusion to Treat a Patient with aBlakpc-2-PositiveKlebsiella pneumoniaeBlood Stream Infection.
Surgical Infections,
Vol. 12,
Issue. 4,
p.
325.
Zarfel, G.
Hoenigl, M.
Würstl, B.
Leitner, E.
Salzer, H.J.F.
Valentin, T.
Posch, J.
Krause, R.
and
Grisold, A.J.
2011.
Emergence of carbapenem-resistant Enterobacteriaceae in Austria, 2001–2010.
Clinical Microbiology and Infection,
Vol. 17,
Issue. 11,
p.
E5.
Neuner, Elizabeth A.
Yeh, Jun-Yen
Hall, Gerri S.
Sekeres, Jennifer
Endimiani, Andrea
Bonomo, Robert A.
Shrestha, Nabin K.
Fraser, Thomas G.
and
van Duin, David
2011.
Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections.
Diagnostic Microbiology and Infectious Disease,
Vol. 69,
Issue. 4,
p.
357.
Nordmann, Patrice
Naas, Thierry
and
Poirel, Laurent
2011.
Global Spread of Carbapenemase-producingEnterobacteriaceae.
Emerging Infectious Diseases,
Vol. 17,
Issue. 10,
p.
1791.
Orsi, Giovanni Battista
Falcone, Marco
and
Venditti, Mario
2011.
Surveillance and management of multidrug-resistant microorganisms.
Expert Review of Anti-infective Therapy,
Vol. 9,
Issue. 8,
p.
653.
Arnold, Ryan S.
Thom, Kerri A.
Sharma, Saarika
Phillips, Michael
Kristie Johnson, J.
and
Morgan, Daniel J.
2011.
Emergence of Klebsiella pneumoniae Carbapenemase-Producing Bacteria.
Southern Medical Journal,
Vol. 104,
Issue. 1,
p.
40.
Orsi, G.B.
García-Fernández, A.
Giordano, A.
Venditti, C.
Bencardino, A.
Gianfreda, R.
Falcone, M.
Carattoli, A.
and
Venditti, M.
2011.
Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients.
Journal of Hospital Infection,
Vol. 78,
Issue. 1,
p.
54.
Balkhy, H. H.
El-Saed, A.
Johani, S. M.
Francis, C.
Al-Qahtani, A. A.
Al-Ahdal, M. N.
Altayeb, H. T.
Arabi, Y.
Alothman, A.
and
Sallah, M.
2012.
The epidemiology of the first described carbapenem-resistant Klebsiella pneumoniae outbreak in a tertiary care hospital in Saudi Arabia: how far do we go?.
European Journal of Clinical Microbiology & Infectious Diseases,
Vol. 31,
Issue. 8,
p.
1901.
Borer, Abraham
Saidel-Odes, Lisa
Eskira, Seada
Nativ, Ronit
Riesenberg, Klaris
Livshiz-Riven, Ilana
Schlaeffer, Francisc
Sherf, Michael
and
Peled, Nejama
2012.
Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae.
American Journal of Infection Control,
Vol. 40,
Issue. 5,
p.
421.
Tzouvelekis, L. S.
Markogiannakis, A.
Psichogiou, M.
Tassios, P. T.
and
Daikos, G. L.
2012.
Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions.
Clinical Microbiology Reviews,
Vol. 25,
Issue. 4,
p.
682.
Ben-David, D.
Kordevani, R.
Keller, N.
Tal, I.
Marzel, A.
Gal-Mor, O.
Maor, Y.
and
Rahav, G.
2012.
Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections.
Clinical Microbiology and Infection,
Vol. 18,
Issue. 1,
p.
54.
Schwaber, Mitchell J.
Carmeli, Yehuda
and
Harbarth, Stephan
2012.
Antibiotic Policies.
p.
105.
Nordmann, Patrice
Dortet, Laurent
and
Poirel, Laurent
2012.
Carbapenem resistance in Enterobacteriaceae: here is the storm!.
Trends in Molecular Medicine,
Vol. 18,
Issue. 5,
p.
263.
Falagas, M. E.
and
Rafailidis, Petros I.
2012.
Colistin in Ventilator-Associated Pneumonia.
Clinical Infectious Diseases,
Vol. 54,
Issue. 5,
p.
681.